Shopping Cart
- Remove All
![TargetMol](https://www.targetmol.com/storage/error/oops.webp)
Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $45 | In Stock | |
5 mg | $118 | In Stock | |
10 mg | $187 | In Stock | |
25 mg | $319 | In Stock | |
50 mg | $460 | In Stock | |
100 mg | $648 | In Stock | |
500 mg | Inquiry | In Stock |
Description | MRS1220, a selective and potent antagonist for the human A3 adenosine receptor (hA3AR) with a dissociation constant (Ki) of 0.59 nM, exhibits therapeutic promise for central nervous system disease research. It effectively diminishes glioblastoma tumor size and inhibits blood vessel formation in vivo. |
In vitro | MRS 1220 reverses the effect of A3 agonist-elicited inhibition of tumor necrosis factor-α formation in the human macrophage U-937 cell line with an IC50 of 0.3 μM[1]. VEGF secretion in U87MG glioblastoma stem-like cells (GSCs) decreases ~25% with MRS1220 after 72 h of hypoxia[2]. |
In vivo | MRS1220 (0.15 mg/kg; intraperitoneal inoculation) reduces tumor size and blood vessel formation in vivo. MRS1220 exhibits a strong in vivo anti-angiogenic effect[2]. |
Alias | MRS 1220 |
Molecular Weight | 403.82 |
Formula | C21H14ClN5O2 |
Cas No. | 183721-15-5 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Solubility Information | DMSO: <1 mg/mL(insoluble or slightly soluble) ![]() |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.